Pancreatic Cancer News and Research

RSS

Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.

Cutting the test time for disease biomarkers using extracellular vesicles

When an individual has cancer, or any number of other diseases, early detection can make a huge difference in the outcome. A research team led by the University of Notre Dame is working to cut the test time for disease biomarkers.

21 May 2019

Early removal of some pancreatic cysts could decrease cancer risk, save lives

By analyzing medical records of 901 adults who had surgery for a certain type of precancerous pancreatic cyst, researchers at Johns Hopkins Medicine and The Karolinska Institute in Sweden have updated parameters for an anatomical “marker” that can tell more precisely if these cysts are likely to develop into lethal pancreatic cancers.

From Johns Hopkins Medicine 15 May 2019

Quanterix corporation releases operating results for first quarter 2019

Quanterix announced financial results for the three months ended March 31, 2019.

From Quanterix 10 May 2019

Study: Type 2 diabetes linked to elevated risk of several cancers

A new Journal of Diabetes study from China, which has the highest number of people with diabetes among all countries, found that type 2 diabetes was linked with an elevated risk of 11 types of cancer in men and 13 types of cancer in women.

9 May 2019

Deletion of ATDC gene prevents development of pancreatic cancer in mice

The action of a gene called ATDC is required for the development of pancreatic cancer, a new study finds.

2 May 2019

Angiotensin receptor blockers could improve response to cancer immunotherapy

A research team led by investigators at Massachusetts General Hospital and the Massachusetts Institute of Technology has found that combining a specialized version of an antihypertension drug with immune checkpoint blockers could increase the effectiveness of cancer immunotherapies.

30 Apr 2019

Prior radioprotection via EGLN inhibitor improves survival in mouse model of pancreatic cancer

Administration of the EGLN inhibitor FG-4592 prior to ablative radiotherapy provided protection against fatal gastrointestinal bleeding and improved survival in a mouse model of unresectable pancreatic cancer.

30 Apr 2019

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

Using human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotransmitter in the spread of aggressive cancers. Neurotransmitters are chemical "messengers" that transmit impulses from neurons to other target cells.

25 Apr 2019

Three studies show how tumors hijack the immune system to develop radiotherapy resistance

More than a decade ago, radiation oncologists noticed a nifty phenomenon: Sometimes radiation used locally against a tumor could excite the immune system to attack cancer systemically throughout the body.

17 Apr 2019

Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs

Before being tested in animals or humans, most cancer drugs are evaluated in tumor cells grown in a lab dish.

17 Apr 2019

Research group develops extremely sensitive pancreatic cancer diagnostic method

Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.

12 Apr 2019

Unusually small antibodies could help CAR T-cell therapies to kill solid tumors

In 1989, two undergraduate students at the Free University of Brussels were asked to test frozen blood serum from camels, and stumbled on a previously unknown kind of antibody. I

12 Apr 2019

Combined inhibition of EGFR and c-RAF kinase shows regression of most aggressive pancreatic cancer

Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.

12 Apr 2019

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

12 Apr 2019

Study finds no statistically significant effect of drug shortages on cancer treatment

For the vast majority of cancer drugs experiencing shortages over a seven-year period, a new USC research study found no statistically significant effect of shortages on chemotherapy treatment.

8 Apr 2019

Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer

A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug's action, research led by the University of Michigan Rogel Cancer Center found.

27 Mar 2019

Study evaluates prescribing of preventive drugs at the end of life in older adults with cancer

A new study reveals that preventive medications--such as those to lower blood pressure or cholesterol, or to protect bone health, among others--are commonly prescribed during the last year of life of older adults with cancer, even though they are unlikely to provide meaningful benefits.

25 Mar 2019

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

22 Mar 2019

Researchers discover possible new therapeutic strategy for pancreatic cancer

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world's deadliest cancers.

21 Mar 2019

USP15 enzyme could potentially lead to new treatments for breast, pancreatic cancer

Researchers at the George Washington University Cancer Center found that the enzyme USP15 could potentially lead to new treatments for breast and pancreatic cancer. Their findings were published in Nature Communications.

15 Mar 2019

Pancreatic Cancer News and Research

Further Reading

Cutting the test time for disease biomarkers using extracellular vesicles

Early removal of some pancreatic cysts could decrease cancer risk, save lives

Quanterix corporation releases operating results for first quarter 2019

Study: Type 2 diabetes linked to elevated risk of several cancers

Deletion of ATDC gene prevents development of pancreatic cancer in mice

Angiotensin receptor blockers could improve response to cancer immunotherapy

Prior radioprotection via EGLN inhibitor improves survival in mouse model of pancreatic cancer

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

Three studies show how tumors hijack the immune system to develop radiotherapy resistance

Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs

Research group develops extremely sensitive pancreatic cancer diagnostic method

Unusually small antibodies could help CAR T-cell therapies to kill solid tumors

Combined inhibition of EGFR and c-RAF kinase shows regression of most aggressive pancreatic cancer

One-third of people with cancer use complementary and alternative medicines

Study finds no statistically significant effect of drug shortages on cancer treatment

Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer

Study evaluates prescribing of preventive drugs at the end of life in older adults with cancer

City of Hope exhibits current studies and data on cancer therapies at AACR

Researchers discover possible new therapeutic strategy for pancreatic cancer

USP15 enzyme could potentially lead to new treatments for breast, pancreatic cancer

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News